Table 2.
Study | Target receptor/pathway |
Target population | Agent |
---|---|---|---|
Li et al.(22) | c-Met | c-MethighCD44+ CD44+CD24+ESA+ |
XL184 |
Rajeshkumar et al.(51) | DR5 | ALDH+ CD44+CD24+ESA+ |
DR5 Agonistic monoclonal antibody |
Lonardo et al.(52) | ALK4 | CD133+ | SB431542 |
Jimeno et al.(11) Feldmann et al.(54) Feldmann et al.(53) |
Hedgehog | ALDH+ CD44+CD24+ESA+ |
Cyclopamine, IPI269609 |
Mullendore et al.(57) | Notch | ALDH+ | GSI-18 |
Zhang et al.(58) | EMT | CD133+ | Salinomycin |